Search Results - "LASALA, John"

4-Year Results of a Randomized Controlled Trial of Percutaneous Repair Versus Surgery for Mitral Regurgitation by Mauri, Laura, MD, Foster, Elyse, MD, Glower, Donald D., MD, Apruzzese, Patricia, MS, Massaro, Joseph M., PhD, Herrmann, Howard C., MD, Hermiller, James, MD, Gray, William, MD, Wang, Andrew, MD, Pedersen, Wesley R., MD, Bajwa, Tanvir, MD, Lasala, John, MD, PhD, Low, Reginald, MD, Grayburn, Paul, MD, Feldman, Ted, MD

“…Objectives This study sought to evaluate 4-year outcomes of percutaneous repair versus surgery for mitral regurgitation. Background Transcatheter therapies are…”
Get full text

Left Ventricular Unloading by Impella Device Versus Surgical Vent During Extracorporeal Life Support by Tepper, Sarah, BS, Masood, Muhammad Faraz, MD, Baltazar Garcia, Moises, BA, Pisani, Molly, BA, Ewald, Gregory A., MD, Lasala, John M., MD, PhD, Bach, Richard G., MD, Singh, Jasvindar, MD, Balsara, Keki R., MD, Itoh, Akinobu, MD, PhD

“…Background Patients supported with extracorporeal life support (ECLS) can experience severe complications from increased left ventricular (LV) afterload. The…”
Get full text

Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention by Kirtane, Ajay J, Doshi, Darshan, Leon, Martin B, Lasala, John M, Ohman, E Magnus, O’Neill, William W, Shroff, Adhir, Cohen, Mauricio G, Palacios, Igor F, Beohar, Nirat, Uriel, Nir, Kapur, Navin K, Karmpaliotis, Dimitri, Lombardi, William, Dangas, George D, Parikh, Manish A, Stone, Gregg W, Moses, Jeffrey W

“…Patients with severe coronary artery disease with a clinical indication for revascularization but who are at high procedural risk because of patient…”
Get full text

Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Standard Care Among Inoperable Patients With Severe Aortic Stenosis: Results From the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B) by REYNOLDS, Matthew R, MAGNUSON, Elizabeth A, SMITH, Craig R, LEON, Martin B, COHEN, David J, KAIJUN WANG, YANG LEI, VILAIN, Katherine, WALCZAK, Joshua, KODALI, Susheel K, LASALA, John M, O'NEILL, William W, DAVIDSON, Charles J

“…In patients with severe aortic stenosis who cannot have surgery, transcatheter aortic valve replacement (TAVR) has been shown to improve survival and quality…”
Get full text

Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patients by Kar, Saibal, Feldman, Ted, Qasim, Atif, Trento, Alfredo, Kapadia, Samir, Pedersen, Wesley, Lim, D Scott, Kipperman, Robert, Smalling, Richard W, Bajwa, Tanvir, Hermann, Howard C, Hermiller, James B, Lasala, John M, Reisman, Mark, Glower, Donald, Mauri, Laura, Whitlow, Patrick

“…This study evaluates the 5-year clinical outcomes of transcatheter mitral valve (MV) repair with the MitraClip device in patients at high risk for MV surgery…”
Get more information

Acute and 12-Month Results With Catheter-Based Mitral Valve Leaflet Repair by Whitlow, Patrick L., MD, Feldman, Ted, MD, Pedersen, Wes R., MD, Lim, D. Scott, MD, Kipperman, Robert, MD, Smalling, Richard, MD, PhD, Bajwa, Tanvir, MD, Herrmann, Howard C., MD, Lasala, John, MD, PhD, Maddux, James T., MD, Tuzcu, Murat, MD, Kapadia, Samir, MD, Trento, Alfredo, MD, Siegel, Robert J., MD, Foster, Elyse, MD, Glower, Donald, MD, Mauri, Laura, MD, Kar, Saibal, MD

“…Objectives The EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study (HRS) assessed the safety and effectiveness of the MitraClip device (Abbott…”
Get full text

Incidence and predictors of coronary stent thrombosis: Evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses by D'Ascenzo, Fabrizio, Bollati, Mario, Clementi, Fabrizio, Castagno, Davide, Lagerqvist, Bo, de la Torre Hernandez, Jose M, ten Berg, Juriën M, Brodie, Bruce R, Urban, Philip, Jensen, Lisette Okkels, Sardi, Gabriel, Waksman, Ron, Lasala, John M, Schulz, Stefanie, Stone, Gregg W, Airoldi, Flavio, Colombo, Antonio, Lemesle, Gilles, Applegate, Robert J, Buonamici, Piergiovanni, Kirtane, Ajay J, Undas, Anetta, Sheiban, Imad, Gaita, Fiorenzo, Sangiorgi, Giuseppe, Modena, Maria Grazia, Frati, Giacomo, Biondi-Zoccai, Giuseppe

“…Abstract Background Stent thrombosis remains among the most feared complications of percutaneous coronary intervention (PCI) with stenting. However, data on…”
Get full text

Learning Alternative Access Approaches for Transcatheter Aortic Valve Replacement: Implications for New Transcatheter Aortic Valve Replacement Centers by Henn, Matthew C., MD, Percival, Thomas, MD, Zajarias, Alan, MD, Melby, Spencer J., MD, Lindman, Brian R., MD, Quader, Nishath, MD, Damiano, Ralph J., MD, Moon, Marc R., MD, Lasala, John M., MD, Rao, Ravinder S., MD, Bell, Jennifer, BSN, Damiano, Marci S., RN, Maniar, Hersh S., MD

“…Background Smaller transcatheter aortic valve replacement (TAVR) delivery systems have increased the number of patients eligible for transfemoral procedures…”
Get full text

Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement by Lindman, Brian R, Breyley, Jared G, Schilling, Joel D, Vatterott, Anna M, Zajarias, Alan, Maniar, Hersh S, Damiano, Jr, Ralph J, Moon, Marc R, Lawton, Jennifer S, Gage, Brian F, Sintek, Marc A, Aquino, Alejandro, Holley, Christopher L, Patel, Neil M, Lawler, Cassandra, Lasala, John M, Novak, Eric

“…In heart failure populations without aortic stenosis (AS), the prognostic utility of multiple biomarkers in addition to clinical factors has been demonstrated…”
Get more information

Delirium after surgical and transcatheter aortic valve replacement is associated with increased mortality by Maniar, Hersh S., MD, Lindman, Brian R., MD, Escallier, Krisztina, MD, Avidan, Michael, MD, Novak, Eric, MS, Melby, Spencer J., MD, Damiano, Marci S., RN, MSN, Lasala, John, MD, Quader, Nishath, MD, Rao, Ravinder Singh, MD, Lawton, Jennifer, MD, Moon, Marc R., MD, Helsten, Daniel, MD, Pasque, Michael K., MD, Damiano, Ralph J., MD, Zajarias, Alan, MD

“…Abstract Objective The purpose of this study was to determine the incidence and clinical significance of postoperative delirium (PD) in patients with aortic…”
Get full text

Systemic inflammatory response syndrome after transcatheter or surgical aortic valve replacement by Lindman, Brian R, Goldstein, Jacob S, Nassif, Michael E, Zajarias, Alan, Novak, Eric, Tibrewala, Anjan, Vatterott, Anna M, Lawler, Cassandra, Damiano, Ralph J, Moon, Marc R, Lawton, Jennifer S, Lasala, John M, Maniar, Hersh S

“…An inflammatory response after cardiac surgery is associated with worse clinical outcomes, but recent trials to attenuate it have been neutral. We evaluated…”
Get more information

Anesthetic Considerations for the Transcatheter Management of Mitral Valve Disease by Gregory, Stephen H., Sodhi, Nishtha, Zoller, Jonathan K., Quader, Nishath, Ridley, Clare H., Maniar, Hersh S., Lasala, John M., Zajarias, Alan

“…The development of transcatheter interventions to provide a minimally invasive alternative to open surgical repair has revolutionized the care of patients with…”
Get full text

Observed to expected 30-day mortality as a benchmark for transcatheter aortic valve replacement by Henn, Matthew C., Zajarias, Alan, Quader, Nishath, Sintek, Marc, Lasala, John M., Koogler, Kelly, Damiano, Marci S., Kachroo, Puja, Miller, D. Craig, King, C. Ryan, Melby, Spencer J., Moon, Marc R., Damiano, Ralph J., Maniar, Hersh S.

“…The observed-to-expected 30-day mortality ratio (O:E ratio) is a standard metric by which transcatheter aortic valve replacement (TAVR) trials have been…”
Get full text

Preoperative pulmonary function tests predict mortality after surgical or transcatheter aortic valve replacement by Henn, Matthew C., MD, Zajarias, Alan, MD, Lindman, Brian R., MD, Greenberg, Jason W., BS, Melby, Spencer J., MD, Quader, Nishath, MD, Vatterott, Anna M., MPH, Lawler, Cassandra, MSN, Damiano, Marci S., RN, MSN, Novak, Eric, MS, Lasala, John M., MD, Moon, Marc R., MD, Lawton, Jennifer S., MD, Damiano, Ralph J., MD, Maniar, Hersh S., MD

“…Abstract Objectives To determine the role of preoperative pulmonary function tests (PFTs) in patients with aortic stenosis (AS) evaluated for aortic valve…”
Get full text

Novel Patient‐Centered Approach to Facilitate Same‐Day Discharge in Patients Undergoing Elective Percutaneous Coronary Intervention by Amin, Amit P., Crimmins‐Reda, Patricia, Miller, Samantha, Rahn, Brandon, Caruso, Mary, Pierce, Andrew, Dennis, Brandy, Pendegraft, Marissa, Sorensen, Katrine, Kurz, Howard I., Lasala, John M., Zajarias, Alan, Bach, Richard G., Kulkarni, Hemant, Singh, Jasvindar

“…Background Same‐day discharge (SDD) after elective percutaneous coronary intervention is safe, less costly, and preferred by patients, but it is usually…”
Get full text

Impact of intravascular ultrasound on the long-term clinical outcomes in the treatment of coronary ostial lesions by Patel, Yogesh, Depta, Jeremiah P., Patel, Jayendrakumar S., Masrani, Shriti K., Novak, Eric, Zajarias, Alan, Kurz, Howard I., Lasala, John M., Bach, Richard G., Singh, Jasvindar

“…Objectives To evaluate the long‐term outcomes of patients with ostial lesions who underwent percutaneous coronary intervention (PCI) with and without the use…”
Get full text

Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessment by Depta, Jeremiah P, Patel, Jayendrakumar S, Novak, Eric, Gage, Brian F, Masrani, Shriti K, Raymer, David, Facey, Gabrielle, Patel, Yogesh, Zajarias, Alan, Lasala, John M, Amin, Amit P, Kurz, Howard I, Singh, Jasvindar, Bach, Richard G

“…Although lesions deferred revascularization following fractional flow reserve (FFR) assessment have a low risk of adverse cardiac events, variability in risk…”
Get full text

Outcomes of Coronary Stenoses Deferred Revascularization for Borderline Versus Nonborderline Fractional Flow Reserve Values by Depta, Jeremiah P., MD, MPHS, Patel, Jayendrakumar S., MD, Novak, Eric, MS, Masrani, Shriti K., MD, Raymer, David, MD, Facey, Gabrielle, Patel, Yogesh, MD, Zajarias, Alan, MD, Lasala, John M., MD, PhD, Singh, Jasvindar, MD, Bach, Richard G., MD, Kurz, Howard I., MD

“…Current evidence supports deferral of revascularization for lesions with fractional flow reserve (FFR) values >0.80. The natural history after deferral of…”
Get full text

Coronary artery dissection and perforation complicating percutaneous coronary intervention by Rogers, Jason H, Lasala, John M

“…Percutaneous coronary intervention (PCI) is widely utilized in the treatment of symptomatic coronary artery disease. Despite its numerous benefits, serious and…”
Get more information

Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves) by Paradis, Jean-Michel, Maniar, Hersh S, Lasala, John M, Kodali, Susheel, Williams, Mathew, Lindman, Brian R, Damiano, Jr, Ralph J, Moon, Marc R, Makkar, Raj R, Thourani, Vinod H, Babaliaros, Vasilis, Xu, Ke, Ayele, Girma Minalu, Svensson, Lars, Leon, Martin B, Zajarias, Alan

“…This study sought to clarify the clinical and echocardiographic prognostic implication of myocardial injury after transcatheter aortic valve replacement…”
Get full text